Use of Mac‐2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosis

In contrast to patients with viral hepatitis, patients with nonalcoholic fatty liver disease (NAFLD) can progress to hepatocellular carcinoma during the initial stages of liver fibrosis. Development and implementation of noninvasive methods for diagnosis and progression prediction are important for...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamada, Yoshihiro, Ono, Masafumi, Hyogo, Hideyuki, Fujii, Hideki, Sumida, Yoshio, Yamada, Makoto, Mori, Kojiroh, Tanaka, Saiyu, Maekawa, Tomohiro, Ebisutani, Yusuke, Yamamoto, Akiko, Takamatsu, Shinji, Yoneda, Masashi, Kawada, Norifumi, Chayama, Kazuaki, Saibara, Toshiji, Takehara, Tetsuo, Miyoshi, Eiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678915/
https://www.ncbi.nlm.nih.gov/pubmed/29404494
http://dx.doi.org/10.1002/hep4.1080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678915/
https://www.ncbi.nlm.nih.gov/pubmed/29404494
http://dx.doi.org/10.1002/hep4.1080

Ejemplares similares